WVU Rockefeller Neuroscience Institute continues its mission to advance treatment of brain aneurysms with its participation in the clinical trial of a new device called SEAL. SEAL stands for Saccular ...

WVU Rockefeller Neuroscience Institute continues its mission to advance treatment of brain aneurysms with its participation ...

WVU Rockefeller Neuroscience Institute are in next phases of their groundbreaking aneurysm device trial. The Seal-It trials ...

Though it was seven phone generations ago, overstuffing 2017's Galaxy Note 7 infamously led their batteries to catch fire. Samsung could pitch the S25 Edge's thinner size to consumers looking for ...

RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that Cohort 3 of its Phase 1 clinical trial enrolled three patients and all ...

In other recent news, Alterity Therapeutics has announced several key developments. The company has completed a Phase 2 clinical trial, marking a significant step in its drug development programs.

MELBOURNE, Australia and SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX ... placebo-controlled Phase 2 clinical trial in patients with early-stage multiple system atrophy ...

During the Galaxy Unpacked keynote presentation, Samsung officially showcased its next flagship smartphones with the Galaxy S25 series. This includes the Galaxy S25, S25 Plus, and S25 Ultra.

Investing.com -- Shares of Leap Therapeutics (NASDAQ:LPTX) tumbled 64% in pre-open trading Tuesday as the company announced that its DisTinGuish study of sirexatamab combined with tislelizumab and ...

Jan. 27, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ ... overall design of the Company’s planned Phase 3 AURORA trial for Descartes-08, its lead mRNA cell therapy candidate ...

Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25 Cartesian Therapeutics has secured an agreement from the US Food and Drug Administration (FDA) under the Special Protocol Assessment ...